Neurelis is focused on therapies that empower patients, care partners, and healthcare providers. Their unique approach leverages both internal and external innovation and technology platforms to unlock opportunities for better patient care.
For more information on Neurelis, please visit www.Neurelis.com.
“We are very pleased to partner with Sail For Epilepsy in its efforts to raise awareness about epilepsy. Given our shared commitment to helping patients and those who care for them, we were excited to support Sail For Epilepsy’s mission to educate thousands of people around the world about epilepsy.”
Craig Chambliss, President and Chief Executive Officer of Neurelis, Inc.
Greenwich Biosciences is now part of Jazz Pharmaceuticals, a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. They are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options.
Sail For Epilepsy is seeking additional corporate sponsors to support the Sail For Epilepsy program. A portion of all funds will immediately flow through to our partners. Funds from sponsors will be used for a variety of goals. Initially, funds will be used to invest in the equipment necessary for the offshore sailing program, as well as for satellite communications while sailing the oceans. We will constantly communicate with our followers with epilepsy and/or with interests in epilepsy. At the end of the program, all assets will be sold and the resulting funds will be donated to our two partners.
In return for generous support the Sail For Epilepsy program will provide opportunities for corporate advertising: on our website, in our emails, on the sails of the boat, as well as in our videos. Additionally, Phil is happy to provide seminars discussing epilepsy and the sailing adventure.
For details of opportunities, please reach out to [email protected].